Dear all,

I am in meetings now but see that I just received the response from Bayer. Haven’t looked at this yet but forward it here for your consideration.

Haven’t heard back from Rijk Zwaan yet, will call them in case I do not hear from them by tomorrow noon.

Best regards,

Bram

From: Tomas Zaborowski <tomas.zaborowski@bayer.com>
Sent: Thursday, 16 April 2020 15:24
To: Bram de Jonge <Bram.de.Jonge@oxfamnovib.nl>
Cc: Marita Wiggerthale <mwiggerthale@oxfam.de>; Maarten de Vuyst <Maarten.de.Vuyst@oxfamnovib.nl>; Jeffrey Neu <jeffrey.neu@bayer.com>; Naomi Stevens <naomi.stevens@bayer.com>
Subject: Opportunity to comment regarding upcoming report

Bram,

Thank you for giving us the opportunity to provide some comments and to clarify a few points based on the excerpts from the upcoming No Patents on Seeds! report. We fully appreciate that the majority of the attached comments will not be included in the report itself; however, we hope this will help Oxfam in gaining a clearer picture of the situation at the EPO, and the benefits of the patent system to the public and to the inventor. If you are interested, once we all begin to recover from COVID-19 and the impact it has had on all of us, we’d like to continue to engage in a meaningful conversation with you about this topic and others related to agriculture, sustainability, and biodiversity.

Be safe and well,

Tomas

////////////////////

Bayer AG

Public Affairs & Sustainability

Building 6100

40789 Monheim, Germany

Tel:       +49 2173 38-5070

Mobile: +49 152 57561340

E-mail:  tomas.zaborowski@bayer.com

Web:    http://www.bayer.com

Datenschutzhinweise // Data privacy information

/// Vorstand: Werner Baumann, Vorsitzender | Liam Condon, Wolfgang Nickl, Stefan Oelrich, Heiko Schipper

/// Vorsitzender des Aufsichtsrats: Werner Wenning

/// Sitz der Gesellschaft: Leverkusen | Amtsgericht Köln, HRB 48248